Type III autoimmune polyglandular syndrome: association between Type 1 Diabetes mellitus and Hashimoto thyroiditis

Authors

DOI:

https://doi.org/10.33448/rsd-v10i3.13094

Keywords:

Type III autoimmune polyglandular syndrome; Type 1 Diabetes Mellitus; Hashimoto's thyroiditis; Hyperprolactinemia and Gilbert's syndrome.

Abstract

Autoimmune polyglandular syndromes (APSS) are associations of two or more endocrine diseases of autoimmune origin that affect between 5-10% of the population. The grouping of these diseases depends on genetic and environmental factors, their different presentations allow the distinction of the subtypes of APS. The objective is to report the case of a patient with type III A polyglandular autoimmune syndrome, characterized by Hashimoto's thyroiditis and type 1 diabetes mellitus associated with hyperprolactinemia and Gilbert's syndrome. The patient began to show the symptoms of the syndrome at the age of 10 progressively. The treatment of each disease is being carried out, with no specific treatment for the syndrome in the literature.

References

Borba, V. V., Zandman-Goddard, G., & Shoenfeld, Y. (2018). Prolactin and autoimmunity. Frontiers in Immunology, 9(FEB), 1–8. https://doi.org/10.3389/fimmu.2018.00073

Brenta, G., Vaisman, M., Sgarbi, J. A., Bergoglio, L. M., de Andrada, N. C., Bravo, P. P., Orlandi, A. M., & Graf, H. (2013). Diretrizes clínicas práticas para o manejo do hipotiroidismo. Arquivos Brasileiros de Endocrinologia e Metabologia, 57(4), 265–298. https://doi.org/10.1590/S0004-27302013000400003

Czyzyk, A., & Kurzawa, R. (2019). Hyperprolactinemia associated with macroprolactinoma in a 17-year-old: A case report. Case Reports in Women’s Health, 22, e00111. https://doi.org/10.1016/j.crwh.2019.e00111

Dittmar, M., & Kahaly, G. J. (2010). Genetics of the autoimmune polyglandular syndrome type 3 variant. Thyroid : Official Journal of the American Thyroid Association, 20(7), 737–743. https://doi.org/10.1089/thy.2010.1639

Eira, C., Mota, Â., Silvério, R., Monteiro, R., Bastos, M., & Monteiro, A. (2017). Caso Clínico Síndrome Poliglandular Autoimune Tipo III. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 12(2), 200–205.

Fernandes, A. P. M., Maciel, L. M. Z., Foss, M. C., & Donadi, E. A. (2003). Como entender a associação entre o sistema HLA e as doenças auto-imunes endócrinas. Arquivos Brasileiros de Endocrinologia & Metabologia, 47(5), 601–611. https://doi.org/10.1590/s0004-27302003000500015

Gross, J. L., Silveiro, S. P., Camargo, J. L., Reichelt, A. J., & Azevedo, M. J. de. (2002). Diabetes Melito: Diagnóstico, Classificação e Avaliação do Controle Glicêmico. Arquivos Brasileiros de Endocrinologia & Metabologia, 46(1), 16–26. https://doi.org/10.1590/s0004-27302002000100004

Hansen, M. P., Matheis, N., & Kahaly, G. J. (2015). Type 1 diabetes and polyglandular autoimmune syndrome: A review. World Journal of Diabetes, 6(1), 67–79. https://doi.org/10.4239/wjd.v6.i1.67

Kahaly, G. J., & Frommer, L. (2018). Polyglandular autoimmune syndromes. Journal of Endocrinological Investigation, 41(1), 91–98. https://doi.org/10.1007/s40618-017-0740-9

King, D., & Armstrong, M. J. (2019). Overview of Gilbert’s syndrome. Drug and Therapeutics Bulletin, 57(2), 27–31. https://doi.org/10.1136/dtb.2018.000028

Orbach, H., & Shoenfeld, Y. (2007). Hyperprolactinemia and autoimmune diseases. Autoimmunity Reviews, 6(8), 537–542. https://doi.org/10.1016/j.autrev.2006.10.005

Paknys, G., Kondrotas, A. J., & Kėvelaitis, E. (2009). Hašimoto tiroidito rizikos veiksniai ir patogenezė. Medicina (Kaunas), 45(7), 574–583. https://doi.org/10.3390/medicina45070076

Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B., & Roliński, J. (2015). Immune disorders in Hashimoto’s thyroiditis: What do we know so far? Journal of Immunology Research, 2015. https://doi.org/10.1155/2015/979167

Strassburg, C. P. (2010). Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Practice and Research: Clinical Gastroenterology, 24(5), 555–571. https://doi.org/10.1016/j.bpg.2010.07.007

Tan, S. Y., Mei Wong, J. L., Sim, Y. J., Wong, S. S., Mohamed Elhassan, S. A., Tan, S. H., Ling Lim, G. P., Rong Tay, N. W., Annan, N. C., Bhattamisra, S. K., & Candasamy, M. (2019). Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 13(1), 364–372. https://doi.org/10.1016/j.dsx.2018.10.008

Tavares, J. V., & Kahwage, A. M. (2019). Síndrome poliglandular autoimune tipo III: uma rara associação entre doença de graves, vitiligo e miastenia gravis. Revista Eletrônica Acervo Saúde, 11(5), e245. https://doi.org/10.25248/reas.e245.2019

Downloads

Published

11/03/2021

How to Cite

SILVÉRIO, A. P. .; BAZUCO, G. T. .; MEROTTI, I. N. .; BERETENS , J. D. .; MACHADO, S. C. .; SILVÉRIO, A. C. P. . Type III autoimmune polyglandular syndrome: association between Type 1 Diabetes mellitus and Hashimoto thyroiditis. Research, Society and Development, [S. l.], v. 10, n. 3, p. e18510313094, 2021. DOI: 10.33448/rsd-v10i3.13094. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/13094. Acesso em: 12 apr. 2021.

Issue

Section

Health Sciences